Aripiprazole-induced rabbit syndrome: a case report
- 28 October 2008
- journal article
- case report
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 24 (3), 429-431
- https://doi.org/10.1177/0269881108098145
Abstract
Rabbit syndrome (RS) is a rare side effect of prolonged neuroleptic administration characterised by rapid, fine, rhythmic movements of the mouth along a vertical axis. Long-term exposure to the first generation neuroleptics has clearly been associated with RS, but little is known regarding the risk of RS because of the exposure to the newer atypical antipsychotics. Aripiprazole is a new dopaminergic agent and has been reported to be clinically useful as an antipsychotic drug with reduced extrapyramidal motor side effects. In addition, there are some case reports concerning extrapyramidal side effects, which include tardive dyskinesia, parkinsonism and RS associated with aripiprazole. We present the case of a patient who developed RS during treatment with aripiprazole. Potential mechanisms, including D2 receptor occupancy, low anticholinergic properties and dopamine hypersensitivity theory, are discussed. Although studies with aripiprazole have shown a low liability for extrapyramidal side effects, the present case emphasises the need for caution when treating patients with aripiprazole.This publication has 15 references indexed in Scilit:
- Aripiprazole-induced rabbit syndrome in a drug-naive schizophrenic patientSchizophrenia Research, 2008
- Differential Effects of Aripiprazole on D2, 5-HT2, and 5-HT1AReceptor Occupancy in Patients With Schizophrenia: A Triple Tracer PET StudyAmerican Journal of Psychiatry, 2007
- Tardive DyskinesiaSeminars in Neurology, 2007
- Newer antipsychotics and the rabbit syndromeClinical Practice and Epidemiology in Mental Health, 2007
- A model of anticholinergic activity of atypical antipsychotic medicationsSchizophrenia Research, 2006
- Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: A meta analysisSchizophrenia Research, 2006
- A case of Aripiprazole and extra pyramidal side effectsJournal of Psychopharmacology, 2006
- Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode SchizophreniaAmerican Journal of Psychiatry, 2000
- The Rabbit Syndrome and Antiparkinsonian Medication in Schizophrenic PatientsNeuropsychobiology, 1992
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970